Single-agent adjuvant chemotherapy did not improve overall survival when compared to no adjuvant chemotherapy.
The FDA has warned Sanofi about significant deviations from Current Good Manufacturing Practice regulations for active pharmaceutical ingredients.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback